Figure S7 from Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases | Synapse
April 3, 2024Open Access
Figure S7 from Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Supplemental Figure 7. Pattern of pNF-κB expression in human CNS tumors.